Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 38 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ernexa Therapeutics Inc. | 4,000,000 | reported | 10 Feb 2026 | tx 48+78,124,306−9,356,216 |
| Comera Life Sciences Holdings, Inc. | 3,895.53 | reported | 29 Dec 2023 | tx 16+32,485,142.53 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2026 | PURCHASE | Ernexa Therapeutics Inc. | 4,000,000 | 0.50 USD | |
| 10 Feb 2026 | PURCHASE | Ernexa Therapeutics Inc. | 4,000,000 | — | deriv |
| 09 Jun 2025 | PURCHASE | Ernexa Therapeutics Inc. | 21,241,163 | 0.10 USD | |
| 02 Apr 2025 | PURCHASE | Ernexa Therapeutics Inc. | 3,768,397 | 0.10 USD | |
| 29 Oct 2024 | CONVERSION | Ernexa Therapeutics Inc. | 2,819,546 | 0.50 USD | |
| 29 Oct 2024 | PURCHASE | Ernexa Therapeutics Inc. | 1,562,988 | — | |
| 29 Oct 2024 | PURCHASE | Ernexa Therapeutics Inc. | 4,768,783 | — | |
| 29 Oct 2024 | PURCHASE | Ernexa Therapeutics Inc. | 1,237,762 | — | |
| 29 Oct 2024 | PURCHASE | Ernexa Therapeutics Inc. | 5,420,823 | — | |
| 29 Oct 2024 | PURCHASE | Ernexa Therapeutics Inc. | 261,756 | — | |
| 29 Oct 2024 | SALE | Ernexa Therapeutics Inc. | — | — | deriv |
| 29 Oct 2024 | SALE | Ernexa Therapeutics Inc. | — | — | deriv |
| 29 Oct 2024 | SALE | Ernexa Therapeutics Inc. | — | — | deriv |
| 29 Oct 2024 | SALE | Ernexa Therapeutics Inc. | — | — | deriv |
| 29 Oct 2024 | CONVERSION | Ernexa Therapeutics Inc. | — | 0.00 USD | deriv |
| 24 Sept 2024 | PURCHASE | Ernexa Therapeutics Inc. | 3,125,976 | 1368626.00 USD | derivanomaly |
| 23 Sept 2024 | PURCHASE | Ernexa Therapeutics Inc. | 2,475,524 | — | deriv |
| 23 Sept 2024 | PURCHASE | Ernexa Therapeutics Inc. | 523,512 | — | deriv |
| 23 Sept 2024 | PURCHASE | Ernexa Therapeutics Inc. | 83,916 | — | deriv |
| 23 Sept 2024 | PURCHASE | Ernexa Therapeutics Inc. | 83,916 | — | deriv |
| 29 Oct 2024 | SALE | Ernexa Therapeutics Inc. | — | — | deriv |
| 29 Dec 2023 | PURCHASE | Comera Life Sciences Holdings, Inc. | 20,650,908 | 567900.00 USD | derivanomaly |
| 29 Dec 2023 | PURCHASE | Comera Life Sciences Holdings, Inc. | 3,895.53 | 0.00 USD | deriv |
| 27 Dec 2023 | PURCHASE | Comera Life Sciences Holdings, Inc. | — | 500000.00 USD | deriv |
| 14 Dec 2023 | PURCHASE | Ernexa Therapeutics Inc. | 2,307,692 | 0.13 USD | deriv |